| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/01/2009 | WO2009119499A1 Stent |
| 10/01/2009 | WO2009118759A2 Heterocyclic compounds as adenosine receptor antagonist |
| 10/01/2009 | WO2009118753A2 Process for preparation of naratriptan hydrochloride |
| 10/01/2009 | WO2009118359A2 Capsule for the prevention of cardiovascular diseases |
| 10/01/2009 | WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases |
| 10/01/2009 | WO2009117888A1 Phosphodiesterase iii inhibitors, preparation methods and medical uses thereof |
| 10/01/2009 | WO2009099489A3 Compositions and methods for improving cardiovascular health |
| 10/01/2009 | WO2009095162A8 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 10/01/2009 | WO2009065922A3 Organic compounds |
| 10/01/2009 | WO2009065919A3 Organic compounds |
| 10/01/2009 | WO2009033809A3 Use of a peptide as a therapeutic agent |
| 10/01/2009 | WO2009033791A3 Use of a peptide as a therapeutic agent |
| 10/01/2009 | WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent |
| 10/01/2009 | WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 10/01/2009 | WO2007127377A8 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
| 10/01/2009 | US20090247637 Novel Anthranilic Acid Derivatives |
| 10/01/2009 | US20090247633 Nutrient extracts derived from green plant materials |
| 10/01/2009 | US20090247621 Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them |
| 10/01/2009 | US20090247593 N-thiazol-2-yl-benzamide derivatives |
| 10/01/2009 | US20090247588 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents |
| 10/01/2009 | US20090247582 Methods of treating atherosclerosis |
| 10/01/2009 | US20090247572 Agent for treating atrial fibrillation |
| 10/01/2009 | US20090247546 Treatment of Prevention of Valvular Heart Disease with Flibanserin |
| 10/01/2009 | US20090247539 Novel Pharmaceuticals |
| 10/01/2009 | US20090247521 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
| 10/01/2009 | US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension |
| 10/01/2009 | US20090247500 Novel compounds as cannabinoid receptor ligands |
| 10/01/2009 | US20090247471 Inhibitors of cruzipain and other cysteine proteases |
| 10/01/2009 | US20090247465 Novel Use of Bivalirudin in the Treatment of Acute Coronary Syndrome |
| 10/01/2009 | US20090247460 Inhibitor of vascular endothelial cell growth factor |
| 10/01/2009 | US20090246296 Method of treating ischemia/reperfusion injury with nitroxyl donors |
| 10/01/2009 | US20090246252 Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246185 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 10/01/2009 | US20090246183 eNOS mutations useful for gene therapy and therapeutic screening |
| 10/01/2009 | US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 10/01/2009 | US20090246179 Method of treating myocardial injury |
| 10/01/2009 | US20090246166 Pearl Like Polyvinyl Alcohol Particles, Production Process Thereof and Temporary Vascular Embolic Agent |
| 10/01/2009 | US20090246162 Treatment of Chronic Progressive Heart Failure |
| 10/01/2009 | DE202008006741U1 Nährstoffzusammensetzung zur Vitalisierung Nutrient composition for revitalization |
| 10/01/2009 | CA2722620A1 Method of treating peripheral arterial disease |
| 10/01/2009 | CA2720800A1 Capsule for the prevention of cardiovascular diseases |
| 10/01/2009 | CA2719857A1 Leucine-rich peptide compositions and methods for isolation |
| 10/01/2009 | CA2719623A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 10/01/2009 | CA2719605A1 Transdermally absorbable preparation |
| 10/01/2009 | CA2719601A1 A composition for stabilizing .beta.-blocker and transdermally absorbable preparation comprising the same |
| 10/01/2009 | CA2719394A1 Hydroxyquinoxalinecarboxamide derivative |
| 10/01/2009 | CA2718983A1 Heterocyclic compounds as adenosine receptor antagonist |
| 10/01/2009 | CA2717962A1 Human cardiovascular progenitor cells |
| 09/30/2009 | EP2105497A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 09/30/2009 | EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105139A1 Method of producing a dry earthworm powder |
| 09/30/2009 | EP2105137A1 A novel use of bivalirudin in the treatment of acute coronary syndrome |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105132A1 Use of an anti-atherothrombotic compound for the manufacture of medicaments for the treatment of vascular disorders |
| 09/30/2009 | EP2104677A1 Spiropiperidine glycinamide derivatives |
| 09/30/2009 | EP2104534A1 New combination for use in the treatment of inflammatory disorders |
| 09/30/2009 | EP2104504A2 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 09/30/2009 | EP2104499A1 Method and composition for reducing reperfusion injury |
| 09/30/2009 | EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
| 09/30/2009 | CN101544677A Phytosterin fatty acid ester and preparation method thereof |
| 09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101544617A Method for synthesizing ranolazine |
| 09/30/2009 | CN101544614A Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 09/30/2009 | CN101544610A Ligustrazine salt |
| 09/30/2009 | CN101544597A Method for preparing amlodipine |
| 09/30/2009 | CN101544596A Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101543659A Local vascular delivery system of probucol alone or in combination with sirolimus |
| 09/30/2009 | CN101543628A Medicament and preparation thereof for treating hyperlipemia and atherosclerosis |
| 09/30/2009 | CN101543599A Medicine for curing hypertension and preparation method thereof |
| 09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543567A Chinese medicinal preparation for treating cerebral thrombosis |
| 09/30/2009 | CN101543564A Chinese medicinal preparation for treating hemorrhoids matched with message chair and preparation method thereof |
| 09/30/2009 | CN101543553A Traditional Chinese medicine composition for regulating qi-flowing and relieving chest stuffiness and pain and quality control method thereof |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543532A Traditional Chinese medicine for treating coronary disease, angina pectoris and apoplexy sequelae and preparation method thereof |
| 09/30/2009 | CN101543526A Kudzu root total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543518A Ginseng stem leaf total sapogenin oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543516A A detection method for externally applied medicine for hemorrhoids |
| 09/30/2009 | CN101543512A Method for producing dry earthworm powder |
| 09/30/2009 | CN101543508A Composition containing water-soluble polyamino sugar derivatives and application thereof |
| 09/30/2009 | CN101543496A Novel pharmaceutical composition of medicament promoting nerve remodeling and preparation method thereof |
| 09/30/2009 | CN101543493A (SBA-15)-nimodipine medicament and preparation method thereof |
| 09/30/2009 | CN101543489A Compounds as liver X receptor modifier |
| 09/30/2009 | CN101543483A Sinetipin capsule and preparation method and quality detection method thereof |
| 09/30/2009 | CN101543481A Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
| 09/30/2009 | CN101543298A Rutin chewing agent and method for preparing same |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/30/2009 | CN100544709C Oral dispersible pharmaceutical composition of an antithrombotic compound |
| 09/30/2009 | CA2660325A1 Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |